Clinical trial
Phase II Study of Growth Hormone in Children With Cystic Fibrosis
NCT00016445 · University of Utah, Other · Completed
Key facts
| NCT number | NCT00016445 |
|---|---|
| Title | Phase II Study of Growth Hormone in Children With Cystic Fibrosis |
| Lead sponsor | University of Utah, Other |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Cystic Fibrosis |
| Intervention type | Drug |
| Interventions | growth hormone |
| Enrollment | 40 |
| Start date | Feb 1, 2001 |
| Primary completion | Aug 1, 2007 |
| First posted | May 7, 2001 |
| Last update posted | Sep 9, 2008 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: